Equities

Crescita Therapeutics Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CTX:TOR

Crescita Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.47
  • Today's Change0.000 / 0.00%
  • Shares traded5.50k
  • 1 Year change-17.54%
  • Beta0.3068
Data delayed at least 15 minutes, as of Feb 12 2026 17:12 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment is engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. The Manufacturing and Services segment is engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.

  • Revenue in CAD (TTM)22.07m
  • Net income in CAD457.00k
  • Incorporated2016
  • Employees75.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Breakthrough Chemistry Inc0.000.001.81m5.00--0.1067----0.000.000.001.280.00------0.00-26.730.00-32.61-------200.57----0.00-------100.00------
Skinvisible Inc27.24k-668.54k2.77m2.00------101.66-0.102-0.1020.0035-1.850.1417--0.885410,000.00-347.85-664.56----100.0099.36-2,454.60-531.94---0.9495----0.00-14.2676.26---18.80--
CCA Industries Inc8.59m-7.22m4.60m98.00--1.12--0.536-0.7014-0.70140.82820.47880.76161.2511.51---64.02-12.12-85.04-15.5263.4159.87-84.06-12.400.4246-6.030.1915---26.21-14.70-1,347.19---37.46--
Tantech Holdings Ltd57.12m8.31m7.68m46.000.42460.00930.75780.13452.160.593740.7198.730.259957.231.04911,763.903.69-1.874.41-2.1319.9618.3514.21-5.152.84--0.0142---3.79-2.70-128.97---2.71--
PURE Biosciences Inc3.21m-2.96m7.99m11.00------2.49-0.0194-0.01940.021-0.04962.235.996.19214,000.00-206.07-102.64---140.0060.6654.99-92.35-131.280.2973-6.1143.34--12.18-20.4628.39------
Crescita Therapeutics Inc22.07m457.00k8.75m75.0019.250.53824.580.39650.02440.02441.160.87330.99981.8513.86294,200.002.07-3.712.77-4.6651.7757.842.07-5.312.07--0.0289--11.75-2.60-38.47--40.69--
Bemax Inc109.65k-271.72k9.64m--------87.88-164,075.70-164,075.70947.29-921.540.5306-------131.49------2.67---247.80--0.2641-10.18-----72.37---16.44------
Regalworks Media Inc0.00-1.17m14.35m0.00---------0.1518-0.18760.00-0.07090.00-------95,634.64-----------------37.74----------------
Caring Brands Inc-136.18bn-136.18bn18.06m4.00------------------------------------------------------------
Shonghoya Intl Group Inc0.00-389.90k24.17m3.00---------0.5683-0.56830.00-6.110.00-------5,014.19-3,392.56---------------0.5412---------144.05------
Big Tree Cloud Holdings Ltd-136.18bn-136.18bn26.64m20.00-------------------------------------------------65.08---5,178.94------
Data as of Feb 12 2026. Currency figures normalised to Crescita Therapeutics Inc's reporting currency: Canadian Dollar CAD

Institutional shareholders

0.89%Per cent of shares held by top holders
HolderShares% Held
Attitude Gesti�n SGIIC SAas of 31 Dec 2025165.72k0.89%
Maxam Capital Management Ltd.as of 30 Jun 20250.000.00%
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.